Ποια είναι η τιμή για MetaStat Inc (MTST)

Η τιμή για MetaStat Inc (MTST) είναι $0.001

Ποια είναι η κεφαλαιοποίηση αγοράς για MetaStat Inc (MTST)

Η κεφαλαιοποίηση αγοράς για MetaStat Inc (MTST) είναι $5.88K

MetaStat Inc (MTST) Τιμή και Κεφαλαιοποίηση Αγοράς

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.

Η τιμή για MTST	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$916,005 $5.88K	NVDA	$5.383T	+91,600,467,145.19%
$752,661 $5.88K	AAPL	$4.423T	+75,266,142,553.36%
$707,907 $5.88K	GOOG	$4.160T	+70,790,699,220.78%
$623,332 $5.88K	MSFT	$3.663T	+62,333,177,320.45%
$491,957 $5.88K	AMZN	$2.891T	+49,195,657,470.19%

Η τιμή για MTST

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$916,005 $5.88K